Evaluating the association between drug use and outcome--should the information from observational studies affect therapeutic use?
Goldbourt
U
U
Section of Epidemiology, Henry N. Neufeld Cardiac Research Institute, Tel Aviv, Israel. Goldbu1@ccsg.tau.ac.il
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012449:Safety; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers